Screener / SEC EDGAR /CIK 0001628171 /10-K filed Feb 25, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Revolution Medicines, Inc. RVMD

Compare with peers Embed
Insider trades since May 20, 2026

10 insiders sold $109.8M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $109.8M 122 trades by 10 insiders
Sold under a 10b5-1 plan 99% of the value sold, under a plan set up in advance
Traded the most Mark A. Goldsmith $22.3M See Remarks

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $109.8M sold on 21 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Mark A. Goldsmith
See Remarks, Director
-$22.3M Sep 16, 2026
Stephen Michael Kelsey
See Remarks
-$20.5M Sep 16, 2026
Margaret A. Horn
Chief Operating Officer
-$16.9M Sep 16, 2026
Lorence H. Kim
Director
-$15.0M Sep 8, 2026
Jeff Cislini
SVP & General Counsel
-$13.1M Sep 25, 2026
Jack Anders
Chief Financial Officer
-$11.3M Nov 11, 2026
Anthony Mancini
See Remarks
-$6.4M Nov 9, 2026
Elizabeth M. Anderson
Director
-$2.0M Sep 22, 2026
Alan B. Sandler
Chief Development Officer
-$1.3M Sep 29, 2026
Sushil Patel
Director
-$1.0M Jun 29, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 122 open-market sales by officers and directors, 1 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Nov 11, 2026 Jack Anders Sale (10b5-1) -3,499 633K
Nov 11, 2026 Jack Anders Sale (10b5-1) -5,776 1.1M
Nov 11, 2026 Jack Anders Sale (10b5-1) -2,700 494K
Nov 11, 2026 Jack Anders Sale (10b5-1) -1,900 350K
Nov 11, 2026 Jack Anders Sale (10b5-1) -800 148K
Nov 11, 2026 Jack Anders Sale (10b5-1) -400 75K
Nov 11, 2026 Jack Anders Sale (10b5-1) -600 112K
Nov 11, 2026 Jack Anders Sale (10b5-1) -200 38K
Nov 11, 2026 Jack Anders Sale (10b5-1) -500 95K
Nov 11, 2026 Jack Anders Sale (10b5-1) -9,486 1.8M
Nov 11, 2026 Jack Anders Sale (10b5-1) -9,889 1.9M
Nov 9, 2026 Anthony Mancini Sale (10b5-1) -811 162K
Oct 26, 2026 Anthony Mancini Sale (10b5-1) -2,310 432K
Sep 29, 2026 Alan B. Sandler Sale (10b5-1) -2,200 442K
Sep 29, 2026 Alan B. Sandler Sale (10b5-1) -1,609 325K
Sep 29, 2026 Alan B. Sandler Sale (10b5-1) -1,000 203K
Sep 29, 2026 Alan B. Sandler Sale (10b5-1) -1,199 244K
Sep 29, 2026 Alan B. Sandler Sale (10b5-1) -301 62K
Sep 25, 2026 Jeff Cislini Sale (10b5-1) -765 159K
Sep 25, 2026 Anthony Mancini Sale (10b5-1) -3,121 626K
Sep 24, 2026 Anthony Mancini Sale (10b5-1) -587 117K
Sep 22, 2026 Elizabeth M. Anderson Sale (10b5-1) -910 175K
Sep 22, 2026 Elizabeth M. Anderson Sale (10b5-1) -4,985 960K
Sep 22, 2026 Elizabeth M. Anderson Sale (10b5-1) -2,648 512K
Sep 22, 2026 Elizabeth M. Anderson Sale (10b5-1) -1,500 292K
Sep 22, 2026 Elizabeth M. Anderson Sale (10b5-1) -100 20K
Sep 18, 2026 Anthony Mancini Sale (10b5-1) -1,764 347K
Sep 16, 2026 Mark A. Goldsmith Sale (10b5-1) -213 42K
Sep 16, 2026 Mark A. Goldsmith Sale (10b5-1) -13,775 2.7M
Sep 16, 2026 Margaret A. Horn Sale (10b5-1) -76 15K
Sep 16, 2026 Margaret A. Horn Sale (10b5-1) -4,891 975K
Sep 16, 2026 Stephen Michael Kelsey Sale (10b5-1) -85 17K
Sep 16, 2026 Stephen Michael Kelsey Sale (10b5-1) -5,484 1.1M
Sep 16, 2026 Jack Anders Sale (10b5-1) -61 12K
Sep 16, 2026 Jack Anders Sale (10b5-1) -3,992 796K
Sep 16, 2026 Alan B. Sandler Sale (10b5-1) -5 975
Sep 16, 2026 Alan B. Sandler Sale (10b5-1) -336 67K
Sep 16, 2026 Jeff Cislini Sale (10b5-1) -52 10K
Sep 16, 2026 Jeff Cislini Sale (10b5-1) -3,314 660K
Sep 16, 2026 Anthony Mancini Sale (10b5-1) -27 5K
Sep 16, 2026 Anthony Mancini Sale (10b5-1) -1,747 348K
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -800 159K
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -11,833 2.4M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -13,368 2.7M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -21,447 4.3M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -18,869 3.8M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -17,949 3.7M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -4,995 1.0M
Sep 11, 2026 Stephen Michael Kelsey Sale (10b5-1) -3,270 673K
Sep 10, 2026 Anthony Mancini Sale (10b5-1) -6,019 1.2M
Sep 10, 2026 Anthony Mancini Sale (10b5-1) -5,530 1.1M
Sep 10, 2026 Anthony Mancini Sale (10b5-1) -2,420 496K
Sep 10, 2026 Anthony Mancini Sale (10b5-1) -1,179 243K
Sep 10, 2026 Anthony Mancini Sale (10b5-1) -300 62K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -706 146K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -999 207K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -3,587 748K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -2,853 598K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -4,730 996K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -3,844 812K
Sep 8, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -371 79K
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -300 60K
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -6,597 1.3M
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -12,919 2.6M
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -26,160 5.3M
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -7,271 1.5M
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -2,128 437K
Aug 31, 2026 Lorence H. Kim (indirect) Sale (10b5-1) -625 129K
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -5,128 1.1M
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -24,917 5.2M
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -35,938 7.5M
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -3,813 802K
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -6,583 1.4M
Aug 21, 2026 Mark A. Goldsmith Sale (10b5-1) -3,621 768K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -190 39K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -951 198K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -1,351 283K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -136 29K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -245 52K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -127 27K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -177 37K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -937 195K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -1,405 294K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -126 27K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -229 48K
Aug 21, 2026 Mark A. Goldsmith (indirect) Sale (10b5-1) -126 27K
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -3,400 705K
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -17,323 3.6M
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -25,817 5.4M
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -2,540 534K
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -4,500 951K
Aug 21, 2026 Jeff Cislini Sale (10b5-1) -3,314 703K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -300 55K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -900 166K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -1,100 204K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -858 160K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -300 56K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -100 19K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -600 114K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -541 104K
Jun 29, 2026 Sushil Patel Sale (10b5-1) -881 170K
Jun 24, 2026 Jack Anders Sale (10b5-1) -4,553 762K
Jun 24, 2026 Jack Anders Sale (10b5-1) -9,496 1.6M
Jun 24, 2026 Jack Anders Sale (10b5-1) -5,651 956K
Jun 24, 2026 Jack Anders Sale (10b5-1) -300 51K
Jun 17, 2026 Margaret A. Horn Sale (10b5-1) -29,600 4.7M
Jun 16, 2026 Stephen Michael Kelsey Sale (10b5-1) -4,175 652K
Jun 16, 2026 Jack Anders Sale (10b5-1) -2,722 425K
Jun 16, 2026 Jeff Cislini Sale (10b5-1) -2,157 337K
Jun 16, 2026 Mark A. Goldsmith Sale (10b5-1) -10,020 1.6M
Jun 16, 2026 Anthony Mancini Sale -4,615 720K
Jun 15, 2026 Margaret A. Horn Sale (10b5-1) -60,400 9.7M
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -1,315 190K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -885 128K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -700 102K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -500 74K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -1,800 268K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -4,600 688K
Jun 11, 2026 Margaret A. Horn Sale (10b5-1) -200 30K
May 26, 2026 Anthony Mancini Sale (10b5-1) -700 107K
May 26, 2026 Anthony Mancini Sale (10b5-1) -2,000 308K
May 26, 2026 Anthony Mancini Sale (10b5-1) -421 65K
Show the other 107 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RVMD/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.